Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CMS Awards Monteris Add-On Payment For Tumor Ablation Catheter

This article was originally published in The Gray Sheet

Executive Summary

Monteris Medical expects to deploy its AutoLITT tumor ablation catheter to the market "slowly and methodically" following a favorable Medicare reimbursement decision, according to Jim Duncan, the firm's CEO

You may also be interested in...

Cook’s Zenith Fenestrated AAA Graft Nets Positive Payment Rulings In Medicare Reg

The firm’s specialized endovascular abdominal aortic aneurysm product was the only device newly awarded a new-technology add-on payment for fiscal 2013, and was moved to a higher-paying procedure category than CMS had previously proposed.

People In Brief

Monteris Medical gets a new CEO. Zeltiq's chief executive resigns. More moves by movers and shakers in the medical device and diagnostics industries.

CMS In Brief

Proposed rulemaking limits MRI coverage for pacemaker/defibrillator patients

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts